Get started
Author

Jia Yang

Prognostic Nutritional Index as a Predictor of Diabetic Nephropathy Progression
2022 · Junlin Zhang, Xiang Xiao, et al. · Nutrients · 65
PDF
Efficacy and safety of drugs for people with type 2 diabetes mellitus and chronic kidney disease on kidney and cardiovascular outcomes: A systematic review and network meta-analysis of randomized controlled trials
2023 · Qing Yang, Yanlin Lang, et al. · Diabetes Research and Clinical Practice · 54
Lower bile acids as an independent risk factor for renal outcomes in patients with type 2 diabetes mellitus and biopsy-proven diabetic kidney disease
2022 · Xiang Xiao, Junlin Zhang, et al. · Frontiers in Endocrinology · 22
PDF
From nonalcoholic fatty liver disease to neuroinflammation: the role of chronic systemic inflammation
2025 · Xupeng Huang, Ziqi Sang, et al. · Metabolic Brain Disease · 17
PDF
Remnant cholesterol and the risk of diabetic nephropathy progression to end-stage kidney disease in patients with type 2 diabetes mellitus: a longitudinal cohort study
2024 · Yuancheng Zhao, Ke Liu, et al. · Endocrine · 11
PDF
Estimated small dense low-density lipoprotein-cholesterol and the risk of kidney and cardiovascular outcomes in diabetic kidney disease
2024 · Qing Yang, Yutong Zou, et al. · Renal Failure · 9
PDF
Mechanism of TGR5 in Ferroptosis of the Renal Tubular Epithelial Cells in Diabetes Mellitus and the Effect of Notoginsenoside Ft1
2025 · Xiang Xiao, Junlin Zhang, et al. · The FASEB Journal · 7
Metabolic phenotypes and risk of end-stage kidney disease in patients with type 2 diabetes
2023 · Lijun Zhao, Yutong Zou, et al. · Frontiers in Endocrinology · 6
PDF
The prognostic impact of the Stress Hyperglycemia Ratio on End‐Stage Renal Disease among patients with Diabetic Kidney Disease
2024 · Yutong Zou, Qing Yang, et al. · Diabetes Obesity and Metabolism · 5
PDF
COVID-19 in discharged patients with diabetes and chronic kidney disease: one-year follow-up and evaluation
2025 · Enrong Ran, Yutong Zou, et al. · Frontiers in Endocrinology · 4
Comparative clinical outcomes and safety of finerenone, SGLT2 inhibitors, RAS inhibitors and ARNI in heart failure with preserved or mildly reduced ejection fraction: a systematic review and network meta-analysis
2026 · Zimin Fu, Xin Chen, et al. · Frontiers in Pharmacology · 1
PDF
Effectiveness of Sodium-Glucose Transporter 2 Inhibitors and Semaglutide on Body Composition in Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Real-World Cohort Study with Bioelectrical Impedance Analysis
2025 · Qing Yang, Chunmei Qin, et al. · Diabetes Metabolic Syndrome and Obesity · 1
Intravitreal vascular endothelial growth factor inhibitors did not increase the risk of end-stage renal disease in patients with biopsy-proven diabetic kidney disease based on matched study
2022 · Xiang Xiao, Junlin Zhang, et al. · Frontiers in Pharmacology · 1
PDF
Sex differences in the association between fatty liver index and biological aging: A mediation analysis of insulin resistance in a cross-sectional study
2025 · Jia Yang, Haifeng Liu, et al. · Medicine
Association of total fish-shellfish consumption with biological aging: a cross-sectional analysis of NHANES 1999–2020 with mediation by inflammatory and antioxidant biomarkers
2025 · Haifeng Liu, Jia Yang, et al. · Irish Journal of Medical Science (1971 -)
Associations of sunlight affinity with depression and sleep disorders in American males: Evidence from NHANES 2009–2020
2025 · Haifeng Liu, Jia Yang, et al. · PLoS ONE
PDF
Sex differences in the association between visceral adiposity index and biological aging: A cross-sectional analysis of NHANES 1999–2018 with mediation by insulin resistance
2025 · Jia Yang, Haifeng Liu, et al. · PLoS ONE
PDF
Author response for "The prognostic impact of the Stress Hyperglycemia Ratio on End‐Stage Renal Disease among patients with Diabetic Kidney Disease"
2024 · Yutong Zou, Qing Yang, et al.
Works count: 18
Citation count: 202
H-index: 7
I10-index: 5
Year
Topic
Type